The Division of Cancer at Imperial College London seeks a candidate posessing a PhD or equivalent qualification in biochemistry, pharmacology or a related subject to join its 300-strong team engaged in basic and translational cancer research.

The successful candidate will work on a project investigating mechanisms of nuclear receptor action in breast cancer - particularly centred on chromatin immunoprecipitation and microarray studies to identify target genes - and will be involved in the development of new inhibitors of nuclear receptors implicated in breast cancer, their evaluation as cancer therapeutics and subsequent preclinical development.

The deadline for applications is 25 November 2010. For more information please follow the link below.

Further details